Virginia Retirement Systems’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.36M | Buy |
4,300
+2,800
| +187% | +$660K | 0.01% | 649 |
|
|
2026
Q1 | $299K | Hold |
1,500
| – | – | ﹤0.01% | 847 |
|
|
2025
Q4 | $284K | Buy |
+1,500
| New | +$288K | ﹤0.01% | 860 |
|
|
2020
Q3 | – | Sell |
-11,061
| Closed | -$772K | – | 1133 |
|
|
2020
Q2 | $772K | Sell |
11,061
-4,168
| -27% | -$264K | 0.01% | 668 |
|
|
2020
Q1 | $691K | Sell |
15,229
-5,129
| -25% | -$291K | 0.01% | 682 |
|
|
2019
Q4 | $1.32M | Buy |
20,358
+3,526
| +21% | +$236K | 0.01% | 580 |
|
|
2019
Q3 | $1.04M | Buy |
16,832
+1,764
| +12% | +$111K | 0.01% | 676 |
|
|
2019
Q2 | $1.07M | Buy |
15,068
+481
| +3% | +$35.4K | 0.01% | 654 |
|
|
2019
Q1 | $1.14M | Buy |
14,587
+1,923
| +15% | +$146K | 0.01% | 627 |
|
|
2018
Q4 | $1.07M | Buy |
12,664
+481
| +4% | +$51.3K | 0.01% | 596 |
|
|
2018
Q3 | $2.09M | Sell |
12,183
-1,603
| -12% | -$242K | 0.02% | 459 |
|
|
2018
Q2 | $1.78M | Sell |
13,786
-2,404
| -15% | -$268K | 0.02% | 479 |
|
|
2018
Q1 | $1.67M | Buy |
16,190
+10,419
| +181% | +$1.03M | 0.02% | 503 |
|
|
2017
Q4 | $493K | Buy |
+5,771
| New | +$500K | 0.01% | 813 |
|
|
2017
Q3 | – | Sell |
-6,733
| Closed | -$510K | – | 1075 |
|
|
2017
Q2 | $510K | Sell |
6,733
-17,312
| -72% | -$1.21M | 0.01% | 832 |
|
|
2017
Q1 | $1.59M | Buy |
24,045
+1,282
| +6% | +$84.3K | 0.02% | 532 |
|
|
2016
Q4 | $1.44M | Buy |
22,763
+2,084
| +10% | +$132K | 0.02% | 490 |
|
|
2016
Q3 | $1.32M | Buy |
20,679
+481
| +2% | +$35.3K | 0.02% | 496 |
|
|
2016
Q2 | $1.5M | Buy |
+20,198
| New | +$1.5M | 0.02% | 445 |
|
|
2015
Q4 | $1.52M | Sell |
22,442
-802
| -3% | -$49.5K | 0.02% | 428 |
|
|
2015
Q3 | $1.24M | Sell |
23,244
-3,686
| -14% | -$224K | 0.02% | 461 |
|
|
2015
Q2 | $1.7M | Sell |
26,930
-4,809
| -15% | -$262K | 0.03% | 391 |
|
|
2015
Q1 | $1.53M | Sell |
31,739
-4,008
| -11% | -$154K | 0.02% | 427 |
|
|
2014
Q4 | $1.19M | Buy |
35,747
+7,214
| +25% | +$235K | 0.02% | 469 |
|
|
2014
Q3 | $836K | Buy |
+28,533
| New | +$947K | 0.01% | 561 |
|
|
2014
Q2 | – | Sell |
-8,496
| Closed | -$357K | – | 981 |
|
|
2014
Q1 | $357K | Buy |
8,496
+1,603
| +23% | +$66.8K | 0.01% | 746 |
|
|
2013
Q4 | $226K | Sell |
6,893
-26,930
| -80% | -$877K | ﹤0.01% | 802 |
|
|
2013
Q3 | $913K | Sell |
33,823
-1,924
| -5% | -$54.1K | 0.02% | 489 |
|
|
2013
Q2 | $834K | Buy |
+35,747
| New | +$643K | 0.02% | 514 |
|
Other funds holding LGND
JT
CAM
Virginia Retirement Systems's LGND Position: Q2 2026 in Review
Virginia Retirement Systems increased its Ligand Pharmaceuticals (LGND) stake by 187% in Q2 2026, buying an estimated $660K and bringing the position to 4,300 shares worth $1.36M. The position accounts for 0.01% of the portfolio, ranked #649.
Virginia Retirement Systems first reported a position in LGND in Q2 2013 and has held it in 29 quarters since. The position peaked at $2.09M in Q3 2018. 416 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- Virginia Retirement Systems held 4,300 shares of Ligand Pharmaceuticals worth $1.36M as of Q2 2026.
- Virginia Retirement Systems bought 2,800 Ligand Pharmaceuticals shares in Q2 2026, an estimated $660K.
- Ligand Pharmaceuticals made up 0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #649 holding.
- Virginia Retirement Systems first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 29 quarters since.
- Virginia Retirement Systems's Ligand Pharmaceuticals position peaked at $2.09M in Q3 2018.
- 416 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.